L. O’Mahony

National University of Ireland

Health Outcomes Studied

• Increased Regulatory T Cell Count
• Reduced Abdominal Pain
• Reduced Colitis-Related Mortality
• Reduced Flatulence
• Reduced Straining

Papers (11)

• 2021
  An Exopolysaccharide Produced by Bifidobacterium longum 35624® Inhibits Osteoclast Formation via a TLR2-Dependent Mechanism10.1007/s00223-020-00790-4
• 2016
  Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™10.1371/journal.pone.0162983
• 2016
  The Surface-Associated Exopolysaccharide of Bifidobacterium longum 35624 Plays an Essential Role in Dampening Host Proinflammatory Responses and Repressing Local TH17 Responses10.1128/AEM.02238-16
• 2013
  Bifidobacterium infantis suppression of Peyer's patch MIP-1α and MIP-1β secretion during Salmonella infection correlates with increased local CD4+CD25+ T cell numbers.10.1016/j.cellimm.2013.03.008
• 2013
  Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut10.4161/gmic.25487
• 2008
  Effects of Lactobacillus salivarius 433118 on Intestinal Inflammation, Immunity Status and In vitro Colon Function in Two Mouse Models of Inflammatory Bowel Disease10.1007/s10620-007-0157-y
• 2006
  Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome10.1111/j.1572-0241.2006.00734.x
• 2006
  Comparative and Functional Analysis of Sortase-Dependent Proteins in the Predicted Secretome of Lactobacillus salivarius UCC11810.1128/AEM.03023-05
• 2005Primary author
  Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.10.1053/J.GASTRO.2004.11.050
• 2001Primary author
  Probiotic impact on microbial flora, inflammation and tumour development in IL‐10 knockout mice10.1046/j.1365-2036.2001.01027.x
• 2001
  In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings.10.1093/ajcn/73.2.386s